Targeting the ‘Undruggable’ Driver Protein, KRAS, in Epithelial Cancers: Current Perspective

10.3390/cells12040631

Saved in:

Bibliographic Details
Main Authors:	Lam, KK, Wong, SH, Cheah, PY
Other Authors:	MICROBIOLOGY AND IMMUNOLOGY
Format:	Review
Published:	MDPI AG 2024
Subjects:	KRAS adoptive cell therapy antibody–drug conjugate bispecific antibody colorectal carcinomas cytosolic antibodies internal cancer drivers macromolecular drug small molecule inhibitor Humans Proto-Oncogene Proteins p21(ras) T-Lymphocytes Pancreatic Neoplasms Antigens Biological Products
Online Access:	https://scholarbank.nus.edu.sg/handle/10635/248900
Tags:	Add Tag No Tags, Be the first to tag this record!
Institution:	National University of Singapore

id	sg-nus-scholar.10635-248900
record_format	dspace
spelling	sg-nus-scholar.10635-2489002024-11-13T21:32:33Z Targeting the ‘Undruggable’ Driver Protein, KRAS, in Epithelial Cancers: Current Perspective Lam, KK Wong, SH Cheah, PY MICROBIOLOGY AND IMMUNOLOGY SAW SWEE HOCK SCHOOL OF PUBLIC HEALTH Assoc Prof Peh Yean Cheah KRAS adoptive cell therapy antibody–drug conjugate bispecific antibody colorectal carcinomas cytosolic antibodies internal cancer drivers macromolecular drug small molecule inhibitor Humans Proto-Oncogene Proteins p21(ras) T-Lymphocytes Pancreatic Neoplasms Antigens Biological Products 10.3390/cells12040631 Cells 12 4 631- 2024-06-14T07:06:32Z 2024-06-14T07:06:32Z 2023-02-01 2024-06-11T03:53:08Z Review Lam, KK, Wong, SH, Cheah, PY (2023-02-01). Targeting the ‘Undruggable’ Driver Protein, KRAS, in Epithelial Cancers: Current Perspective. Cells 12 (4) : 631-. ScholarBank@NUS Repository. https://doi.org/10.3390/cells12040631 2073-4409 https://scholarbank.nus.edu.sg/handle/10635/248900 MDPI AG Elements
institution	National University of Singapore
building	NUS Library
continent	Asia
country	Singapore Singapore
content_provider	NUS Library
collection	ScholarBank@NUS
topic	KRAS adoptive cell therapy antibody–drug conjugate bispecific antibody colorectal carcinomas cytosolic antibodies internal cancer drivers macromolecular drug small molecule inhibitor Humans Proto-Oncogene Proteins p21(ras) T-Lymphocytes Pancreatic Neoplasms Antigens Biological Products
spellingShingle	KRAS adoptive cell therapy antibody–drug conjugate bispecific antibody colorectal carcinomas cytosolic antibodies internal cancer drivers macromolecular drug small molecule inhibitor Humans Proto-Oncogene Proteins p21(ras) T-Lymphocytes Pancreatic Neoplasms Antigens Biological Products Lam, KK Wong, SH Cheah, PY Targeting the ‘Undruggable’ Driver Protein, KRAS, in Epithelial Cancers: Current Perspective
description	10.3390/cells12040631
author2	MICROBIOLOGY AND IMMUNOLOGY
author_facet	MICROBIOLOGY AND IMMUNOLOGY Lam, KK Wong, SH Cheah, PY
format	Review
author	Lam, KK Wong, SH Cheah, PY
author_sort	Lam, KK
title	Targeting the ‘Undruggable’ Driver Protein, KRAS, in Epithelial Cancers: Current Perspective
title_short	Targeting the ‘Undruggable’ Driver Protein, KRAS, in Epithelial Cancers: Current Perspective
title_full	Targeting the ‘Undruggable’ Driver Protein, KRAS, in Epithelial Cancers: Current Perspective
title_fullStr	Targeting the ‘Undruggable’ Driver Protein, KRAS, in Epithelial Cancers: Current Perspective
title_full_unstemmed	Targeting the ‘Undruggable’ Driver Protein, KRAS, in Epithelial Cancers: Current Perspective
title_sort	targeting the ‘undruggable’ driver protein, kras, in epithelial cancers: current perspective
publisher	MDPI AG
publishDate	2024
url	https://scholarbank.nus.edu.sg/handle/10635/248900
_version_	1821194959348301824

Targeting the ‘Undruggable’ Driver Protein, KRAS, in Epithelial Cancers: Current Perspective

Similar Items